首页 | 本学科首页   官方微博 | 高级检索  
检索        

PARP抑制剂olaparib对急性髓系白血病细胞HL-60抑制作用研究
引用本文:朱志超,白煜,卢绪章,孙,晓,何流漾,戚春建.PARP抑制剂olaparib对急性髓系白血病细胞HL-60抑制作用研究[J].实用肿瘤学杂志,2019,33(6):481-485.
作者姓名:朱志超  白煜  卢绪章      何流漾  戚春建
作者单位:1.南京医科大学附属常州市第二人民医院中心实验室(常州 213000); 2.南京医科大学附属常州市第二人民医院血液科
基金项目:国家自然科学基金面上项目(编号:81672799);常州市卫生计生委青年人才科技项目(编号:QN201821);南京医科大学科技发展基金面上项目(编号:2017NJMU044)
摘    要:目的 研究PARP抑制剂olaparib对人急性髓系白血病细胞株HL-60细胞的抑制作用。方法 对数生长期HL-60细胞经不同浓度(0、1.25、2.5、5、10 μmol/L)olaparib作用不同时间后,CCK-8法检测olaparib对HL-60细胞的增殖抑制作用;Annexin-V/PI双标法检测HL-60细胞凋亡水平,Western blot检测HL-60细胞内相关信号蛋白(PARP-1、Caspase-3)表达变化。结果 与对照组相比,经不同浓度(1.25、2.5、5、10 μmol/L)olaparib作用48 h后的HL-60细胞出现增殖抑制,并且随着作用时间的延长,抑制率逐渐增加;同时发现olaparib诱导HL-60细胞发生凋亡,并显示出剂量依赖效应;Western blot结果显示,olaparib处理后的HL-60细胞内PARP活性受到抑制,Caspase-3活化。结论 PARP抑制剂olaparib对HL-60细胞不仅具有增殖抑制作用,同时可通过激活Caspase-3,抑制PARP活性,诱导HL-60细胞凋亡。

关 键 词:Olaparib  PARP抑制剂  HL-60细胞  急性髓系白血病  
收稿时间:2019-07-24

Inhibitory effect of PARP inhibitor olaparib on acute myeloid leukemia HL-60 cells
ZHU Zhichao,BAI Yu,LU Xuzhang,SUN Xiao,HE Liuyang,QI Chunjian.Inhibitory effect of PARP inhibitor olaparib on acute myeloid leukemia HL-60 cells[J].Journal of Practical Oncology,2019,33(6):481-485.
Authors:ZHU Zhichao  BAI Yu  LU Xuzhang  SUN Xiao  HE Liuyang  QI Chunjian
Institution:1.The Laboratory Center,The Second People′s Hospital of Changzhou,Affiliated Hospital of Nanjing Medical University,Changzhou 213000,China; 2.Department of Hematology,The Second People′s Hospital of Changzhou
Abstract:Objective The inhibitory effect of the PARP inhibitor olaparib on human acute myeloid leukemia HL-60 cells was studied.Methods The HL-60 cells in logarithmic growth phase were treated with different concentrations(1.25,2.5,5 and 10 μmol/L)of olaparib for different time.The CCK-8 assay was used to detect the inhibitory effect of olaparib on HL-60 cells.The apoptotic level of HL-60 cells was detected by Annexin-V/PI double staining method,and the expression of related signal proteins(PARP-1 and caspase-3)in HL-60 cells was detected by Western blot.Results HL-60 cells were inhibited by olaparib at different concentrations(1.25,2.5,5 and 10 μmol/L)for 48 h,and the inhibition rate gradually increased with the prolongation of the action time;at the same time,the apoptotic rate was increased in HL-60 cells after olaparib treatment for 48 h,showing a dose-dependent manner;the PARP activity was inhibited and caspase-3 was activated in HL-60 cells treated with olaparib.Conclusion The PARP inhibitor olaparib not only inhibits proliferation of HL-60 cells,but it also promotes apoptosis of HL-60 cells by inhibiting PARP activity and activating caspase-3.
Keywords:Olaparib  PARP inhibitor  HL-60 cells  Acute myeloid leukemia  
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号